Ademi LLP is investigating possible securities fraud claims against Zoetis (NYSE: ZTS). The investigation results from inaccurate statements Zoetis may have made regarding its financial statements, business operations and prospects.
On May 7, 2026, Zoetis acknowledged that customers were limiting premium spending for their pets on non-emergency healthcare treatments.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.